<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01792778</url>
  </required_header>
  <id_info>
    <org_study_id>RIGHT IV Pilot Study</org_study_id>
    <nct_id>NCT01792778</nct_id>
  </id_info>
  <brief_title>RIGHT IV Pilot Study</brief_title>
  <acronym>RIGHT IV</acronym>
  <official_title>Post-Market Study Comparing the Clinical Performance Two Blood Control Safety Peripheral Intravenous Catheters: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smiths Medical, ASD, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smiths Medical, ASD, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to collect the necessary information for determining the
      appropriate sample size of a statistically powered trial comparing the performance of two
      different blood control peripheral intravenous catheters.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical performance and acceptability</measure>
    <time_frame>IV catheters will be inserted, secured to subjects, and then immediately removed. Data regarding the insertion process will then be immediately collected.</time_frame>
    <description>Primary outcome measure will be a composite of user ratings evaluating clinical performance and acceptability of each device via a 6-point Likert questionnaire.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Peripheral Intravenous Catheters</condition>
  <arm_group>
    <arm_group_label>ViaValve Safety IV Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Catheter insertion using the ViaValve Safety IV Catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insyte Autoguard BC [Blood Control] Shielded IV Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Catheter insertion using the Insyte Autoguard BC Shielded IV Catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ViaValve Safety IV Catheter</intervention_name>
    <description>Insertion of the peripheral intravenous catheters into both upper extremities of subjects</description>
    <arm_group_label>ViaValve Safety IV Catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Insyte Autoguard BC [Blood Control] Shielded IV Catheter</intervention_name>
    <arm_group_label>Insyte Autoguard BC [Blood Control] Shielded IV Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  Willing and able to independently sign an English Informed Consent

          -  Have adequate veins for placement of IV catheters in both right and left upper
             extremities

        Exclusion Criteria:

          -  Currently taking anti-coagulation medication

          -  Have a known bloodborne disease or bleeding tendency

          -  Have a known fear or adverse reaction to needles or blood

          -  Women who are pregnant or nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lori Schwartz, MBA, MSN, RN, PHN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Smiths Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota Interprofessional Education and Resource Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2013</study_first_submitted>
  <study_first_submitted_qc>February 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>May 25, 2016</last_update_submitted>
  <last_update_submitted_qc>May 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IV Catheters</keyword>
  <keyword>Blood control</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

